PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
04-Sep-2020 Orthobiologics Market To Reach US$ 8,708.4 Million By 2027 Coherent Market Insights
03-Sep-2020 Consumer health specialist joins Research Partnership Inc Research Partnership
03-Sep-2020 Janssen responds to NICE draft guidance not to recommend SPRAVATO®▼ (esketamine) nasal spray for treatment-resistant major depressive disorder Janssen
03-Sep-2020 UK Medicines and Healthcare Products Regulatory Agency issues an Early Access to Medicines Scheme positive scientific opinion for Avelumab as First-Line Maintenance Treatment for patients with Locally Advanced or Metastatic Urothelial Carcinoma Merck
03-Sep-2020 Janssen responds to NICE draft guidance not to recommend SPRAVATO®▼ (esketamine) nasal spray for treatment-resistant major depressive disorder Janssen
03-Sep-2020 Registration is now open for the Pre-filled Syringes and Injectable devices Conference 2021 SMi Group
02-Sep-2020 Senior team at healthcare agency Page & Page become Partners Page & Page & Partners
01-Sep-2020 Oxurion NV Reports First Patient Dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Oxurion NV
01-Sep-2020 Chromologics Announces Seed Round Led by Novo Holdings and Supported by Vækstfonden and Nordic FoodTech VC Chromologics
01-Sep-2020 Oxurion NV Reports First Patient Dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Oxurion NV
01-Sep-2020 4D pharma hosts R&D webinar providing an overview of world leading Live Biotherapeutic discovery platform, MicroRx(R) 4D pharma plc
01-Sep-2020 New 12-month analysis data from ETNA-AF non-interventional study show low bleeding and ICH rates in frail and ageing AF patients on LIXIANA®▼ (edoxaban) during routine clinical care Daiichi Sankyo Europe
01-Sep-2020 NILEMDO®▼(bempedoic acid) delivers cholesterol lowering in addition to statin therapy which is maintained during 2.5 years of treatment Daiichi Sankyo Europe GmbH
01-Sep-2020 Novo Holdings bolsters Principal Investments team with key US appointments Novo Holding A/S
01-Sep-2020 Nordic Nanovector to Present at Upcoming Pareto Securities 11th Healthcare Conference Nordic Nanovector ASA
27-Aug-2020 Celltrion receives Korean MFDS approval to initiate Phase I trial of COVID-19 antiviral antibody treatment candidate, CT-P59, in patients Celltrion Group
27-Aug-2020 Kite, a Gilead Company, to present cell therapy research at the virtual 46th Annual Meeting of the European Society for Blood and Marrow Transplantation Kite, a Gilead Company
27-Aug-2020 PureTech Health plc - Half-Year Report PureTech
27-Aug-2020 Tiziana Life Sciences CEO Updates Shareholders on its Patent Portfolio, Clinical Pipeline, and Strategy in an Exclusive Interview Tiziana Life Sciences plc
27-Aug-2020 BIOCARTIS ANNOUNCES 2020 HALF-YEAR RESULTS ON 3 SEPTEMBER 2020 Biocartis